MapLight Therapeutics Inc
MPLT18.550USD
-0.680-3.54%
收盤 03/27, 16:00（美東）報價延遲15分鐘
768.51M總市值
虧損本益比TTM
關於 公司
MapLight Therapeutics Inc簡介
公司代碼- -
公司名稱- -
上市日期- -
CEO- -
員工數量- -
證券類型- -
年結日- -
公司地址- -
城市- -
上市交易所- -
國家- -
郵編- -
電話- -
網址- -
公司代碼- -
上市日期- -
CEO- -
MapLight Therapeutics Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
259.93K
+2.32%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Chief Accounting Officer, Chief Administrative Officer
Chief Accounting Officer, Chief Administrative Officer
254.52K
+2.37%
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
51.47K
+25.96%
Mr. Vishwas Setia
Mr. Vishwas Setia
Chief Financial Officer
Chief Financial Officer
25.54K
+30.27%
Mr. Robert Malenka, M.D., Ph.D.
Mr. Robert Malenka, M.D., Ph.D.
Director
Director
--
--
Dr. Christopher A. Kroeger, M.D.
Dr. Christopher A. Kroeger, M.D.
Co-Founder, President, Chief Executive Officer, Director
Co-Founder, President, Chief Executive Officer, Director
--
--
Mr. James Lillie, Ph.D.
Mr. James Lillie, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Kristopher L. Hanson
Mr. Kristopher L. Hanson
General Counsel
General Counsel
--
--
Dr. Timothy Garnett
Dr. Timothy Garnett
Independent Director
Independent Director
--
--
Ms. Nanna Luneborg, Ph.D.
Ms. Nanna Luneborg, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
259.93K
+2.32%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Chief Accounting Officer, Chief Administrative Officer
Chief Accounting Officer, Chief Administrative Officer
254.52K
+2.37%
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
51.47K
+25.96%
Mr. Vishwas Setia
Mr. Vishwas Setia
Chief Financial Officer
Chief Financial Officer
25.54K
+30.27%
Mr. Robert Malenka, M.D., Ph.D.
Mr. Robert Malenka, M.D., Ph.D.
Director
Director
--
--
Dr. Christopher A. Kroeger, M.D.
Dr. Christopher A. Kroeger, M.D.
Co-Founder, President, Chief Executive Officer, Director
Co-Founder, President, Chief Executive Officer, Director
--
--
收入明細
由於公司未披露，未能獲取相關數據
由於公司未披露，未能獲取相關數據
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 2月27日 週五
更新時間: 2月27日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Catalyst4 Inc
46.42%
Novo Holdings A/S
8.69%
Forbion Capital Partners
7.60%
T. Rowe Price Investment Management, Inc.
6.60%
Goldman Sachs & Company, Inc.
2.54%
其他
28.16%
持股股東
持股股東
佔比
Catalyst4 Inc
46.42%
Novo Holdings A/S
8.69%
Forbion Capital Partners
7.60%
T. Rowe Price Investment Management, Inc.
6.60%
Goldman Sachs & Company, Inc.
2.54%
其他
28.16%
股東類型
持股股東
佔比
Corporation
45.42%
Venture Capital
20.82%
Investment Advisor
15.30%
Investment Advisor/Hedge Fund
5.27%
Hedge Fund
3.51%
Individual Investor
3.33%
Research Firm
2.51%
Private Equity
1.34%
Endowment Fund
0.44%
其他
2.06%
機構持股
更新時間: 1月21日 週三
更新時間: 1月21日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q4
4
3.81M
0.06%
--
2025Q4
25
7.61M
16.77%
+7.34M
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Catalyst4 Inc
19.70M
43.41%
+19.70M
--
Oct 28, 2025
Novo Holdings A/S
3.69M
8.13%
+3.69M
--
Oct 28, 2025
T. Rowe Price Investment Management, Inc.
11.80K
0.03%
+1.04K
+9.68%
Dec 31, 2025
The Vanguard Group, Inc.
44.63K
0.1%
+23.86K
+114.87%
Nov 30, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
